Glucagon, catecholamine, and symptom responses to hypoglycemia in living donors of pancreas segments

Diabetes

Volumn 52, Issue 7, 2003, Pages 1689-1694

  Robertson, R Paul ^a,c   Sutherland, David E R ^b   Seaquist, Elizabeth R ^b   Lanz, Karla J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARGININE; CATECHOLAMINE; GLUCAGON; INSULIN; NORADRENALIN; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIVING DONOR; MALE; PANCREAS ISLET ALPHA CELL; PANCREAS RESECTION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0037677703     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.7.1689     Document Type: Article

References (20)

1. Kendall DM, Sutherland DE, Najarian JS, Goetz FC, Robertson RP: Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322: 898-903, 1990
2. Seaquist ER, Robertson RP: Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 89: 761-1766, 1992
3. Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte D Jr, Robertson RP: Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans. J Clin Invest 97:455-460, 1996
4. Robertson RP, Lanz KJ, Sutherland DE, Seaquist ER: Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 73:736-741, 2002
5. Kendall DM, Rooney DP, Smets YF, Salazar Bolding L, Robertson RP: Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type 1 diabetes and autonomic neuropathy. Diabetes 46:249-257, 1997
6. Paty B, Ryan E, Shapiro AM, Lakey J, Robertson RP: Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 51:3428-3434, 2002
7. Hoeldtke RD, Boden G, Shuman CR, Owen OE: Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med 96:459-462, 1982
8. Harris V, Faloona GR, Unger RH: Glucagon. In Methods of Hormone Radioimmunoassay. New York, Academic Press, 1979, p. 643-656
9. Evans MI, Halter JB, Porte D Jr. Comparison of double- and single-isotope enzymatic derivative methods for measuring catecholamines in human plasma. Clin Chem 24: 567-570, 1978
10. Gerich JE, Langlois M, Noacco C, Schneider V, Forsham PH: Adrenergic modulation of pancreatic glucagon secretion in man. J Clin Invest 53:1441-1446, 1974
11. Rizza RA, Cryer PE, Gerich JE: Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation: effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest 64:62-71, 1979
12. Shamoon H, Friedman S, Canton C, Zacharowicz L, Hu M, Rossetti L: Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus. J Clin Invest 93:2562-2571, 1994
13. Meneilly GS, Cheung E, Tuokko H: Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 43:403-410, 1994
14. Bolli GB, Tsalikian E, Haymond MW, Cryer PE, Gerich JE: Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus: paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions. J Clin Invest 73:1532-1541, 1984
15. Boden G, Soriano M, Hoeldtke RD, Owen OE: Counterregulatory hormone release and glucose recovery after hypoglycemia in non-insulin-dependent diabetic patients. Diabetes 32:1055-1059, 1983
16. Heller SR, Macdonald IA, Tattersall RB: Counterregulation in type 2 (non-insulin-dependent) diabetes mellitus: normal endocrine and glycaemic responses, up to ten years after diagnosis. Diabetologia 30:924-929, 1987
17. Banarer S, McGregor VP, Cryer PE: Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autononomic response. Diabetes 51:958-965, 2002
18. Segel SA, Paramore DA, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51:724-733, 2002
19. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen [see comments]. N Engl J Med 343:230-238, 2000
20. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157, 2002